Literature DB >> 27063871

A Fluorescence-Labeled Heptapeptide, (FITC)KP6, as an Efficient Probe for the Specific Detection of Oxidized and Minimally Modified Low-Density Lipoprotein.

Akira Sato1, Chiemi Ueda2, Ryu Kimura2, Chisato Kobayashi2, Yoji Yamazaki2, Keiichi Ebina2.   

Abstract

Two oxidized forms of low-density lipoprotein (LDL), oxidized LDL (ox-LDL) and minimally modified LDL (MM-LDL), are believed to play a major role in the pathogenesis of atherosclerosis. Recently, we reported that a heptapeptide (Lys-Trp-Tyr-Lys-Asp-Gly-Asp, KP6) coupled through the ε-amino group of N-terminus Lys to fluorescein isothiocyanate, (FITC)KP6, bound to ox-LDL but not to LDL. In the present study, we investigated whether (FITC)KP6 could be used as a fluorescent probe for the specific detection of MM-LDL and ox-LDL. Results from polyacrylamide gel electrophoresis and surface plasmon resonance proved that (FITC)KP6 could efficiently bind to MM-LDL as well as ox-LDL in a dose-dependent manner and with high affinity (K D = 3.16 and 3.54 ng/mL protein for MM-LDL and ox-LDL, respectively). (FITC) KP6 bound to lysophosphatidylcholine and oxidized phosphatidylcholine, both present abundantly in ox-LDL and MM-LDL, respectively. In vitro, (FITC)KP6 was detected on the surface and/or in the cytosol of human THP-1-derived macrophages incubated with ox-LDL and MM-LDL, but not LDL. These results suggest that (FITC)KP6 could be an efficient fluorescent probe for the specific detection of ox-LDL and MM-LDL and can therefore contribute to the identification, diagnosis, prevention, and treatment of atherosclerosis.

Entities:  

Keywords:  Atherosclerosis; Fluorescence; Heptapeptide; Minimally modified LDL; Oxidized LDL; Probe

Mesh:

Substances:

Year:  2016        PMID: 27063871     DOI: 10.1007/s10895-016-1808-1

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  40 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  Increased endothelial cell turnover in areas of in vivo Evans Blue uptake in the pig aorta.

Authors:  B A Caplan; C J Schwartz
Journal:  Atherosclerosis       Date:  1973 May-Jun       Impact factor: 5.162

3.  Oxidized LDL in carotid plaques and plasma associates with plaque instability.

Authors:  Kyoko Nishi; Hiroyuki Itabe; Masaaki Uno; Keiko T Kitazato; Hidehisa Horiguchi; Kiyohito Shinno; Shinji Nagahiro
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-10-01       Impact factor: 8.311

4.  Oxidized low-density lipoprotein-binding specificity of the Asp-hemolysin-related synthetic peptides from Aspergillus fumigatus.

Authors:  Takeshi Kumagai; Hiromu Tsutsumi; Norihiro Ogawa; Saori Naito; Keiichi Ebina; Katsushi Yokota; Kiyoshi Nagata
Journal:  Biol Pharm Bull       Date:  2006-11       Impact factor: 2.233

5.  A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides.

Authors:  H Itabe; E Takeshima; H Iwasaki; J Kimura; Y Yoshida; T Imanaka; T Takano
Journal:  J Biol Chem       Date:  1994-05-27       Impact factor: 5.157

6.  Characterization of a more electronegatively charged LDL subfraction by ion exchange HPLC.

Authors:  G Cazzolato; P Avogaro; G Bittolo-Bon
Journal:  Free Radic Biol Med       Date:  1991       Impact factor: 7.376

7.  Suppression of endothelin-1 secretion by lysophosphatidylcholine in oxidized low density lipoprotein in cultured vascular endothelial cells.

Authors:  M Jougasaki; K Kugiyama; Y Saito; K Nakao; H Imura; H Yasue
Journal:  Circ Res       Date:  1992-09       Impact factor: 17.367

8.  Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-).

Authors:  H N Hodis; D M Kramsch; P Avogaro; G Bittolo-Bon; G Cazzolato; J Hwang; H Peterson; A Sevanian
Journal:  J Lipid Res       Date:  1994-04       Impact factor: 5.922

9.  The Dynamics of Oxidized LDL during Atherogenesis.

Authors:  Hiroyuki Itabe; Takashi Obama; Rina Kato
Journal:  J Lipids       Date:  2011-05-11

10.  Bid binding to negatively charged phospholipids may not be required for its pro-apoptotic activity in vivo.

Authors:  Anna Manara; Jennefer Lindsay; Marta Marchioretto; Alessandra Astegno; Andrew P Gilmore; Mauro Degli Esposti; Massimo Crimi
Journal:  Biochim Biophys Acta       Date:  2009-05-20
View more
  3 in total

1.  Angiotensin II induces the aggregation of native and oxidized low-density lipoprotein.

Authors:  Akira Sato; Chiemi Ueda; Ryu Kimura; Chisato Kobayashi; Yoji Yamazaki; Keiichi Ebina
Journal:  Eur Biophys J       Date:  2017-04-11       Impact factor: 1.733

2.  A Method for In Vitro Measurement of Oxidized Low-Density Lipoprotein in Blood, Using Its Antibody, Fluorescence-Labeled Heptapeptide and Polyethylene Glycol.

Authors:  Akira Sato; Yoji Yamazaki; Keiichi Ebina
Journal:  J Fluoresc       Date:  2017-07-07       Impact factor: 2.217

3.  Synthesis, Characterization, and Specific Localization of Mitochondrial-Targeted Antioxidant Peptide SS31 Probe.

Authors:  Yuan He; Ruixue Zhang; Zhuoya Quan; Beilei He; Yun Xu; Zejun Chen; Yuan Ren; Xu Liu
Journal:  Biomed Res Int       Date:  2021-05-19       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.